CN106072564A - 一种肝功能衰竭患者特殊医学用途配方食品 - Google Patents
一种肝功能衰竭患者特殊医学用途配方食品 Download PDFInfo
- Publication number
- CN106072564A CN106072564A CN201610508911.4A CN201610508911A CN106072564A CN 106072564 A CN106072564 A CN 106072564A CN 201610508911 A CN201610508911 A CN 201610508911A CN 106072564 A CN106072564 A CN 106072564A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- essence
- powder
- liver failure
- formula food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 18
- 206010019663 Hepatic failure Diseases 0.000 title claims abstract description 16
- 208000007903 liver failure Diseases 0.000 title claims abstract description 16
- 231100000835 liver failure Toxicity 0.000 title claims abstract description 16
- 239000003814 drug Substances 0.000 title claims abstract description 15
- 239000000843 powder Substances 0.000 claims abstract description 19
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 10
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 10
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 10
- 239000011707 mineral Substances 0.000 claims abstract description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 8
- 229940088594 vitamin Drugs 0.000 claims abstract description 8
- 229930003231 vitamin Natural products 0.000 claims abstract description 8
- 235000013343 vitamin Nutrition 0.000 claims abstract description 8
- 239000011782 vitamin Substances 0.000 claims abstract description 8
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 7
- -1 compound vitamin Chemical class 0.000 claims abstract description 7
- 229920001353 Dextrin Polymers 0.000 claims abstract description 5
- 239000004375 Dextrin Substances 0.000 claims abstract description 5
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 claims abstract description 5
- 102000004407 Lactalbumin Human genes 0.000 claims abstract description 5
- 108090000942 Lactalbumin Proteins 0.000 claims abstract description 5
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 5
- 239000002131 composite material Substances 0.000 claims abstract description 5
- 235000005822 corn Nutrition 0.000 claims abstract description 5
- 235000019425 dextrin Nutrition 0.000 claims abstract description 5
- 210000002969 egg yolk Anatomy 0.000 claims abstract description 5
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims abstract description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 5
- 239000000811 xylitol Substances 0.000 claims abstract description 5
- 229960002675 xylitol Drugs 0.000 claims abstract description 5
- 235000010447 xylitol Nutrition 0.000 claims abstract description 5
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 240000008042 Zea mays Species 0.000 claims description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- 229960002685 biotin Drugs 0.000 claims description 4
- 235000020958 biotin Nutrition 0.000 claims description 4
- 239000011616 biotin Substances 0.000 claims description 4
- 239000011575 calcium Substances 0.000 claims description 4
- 229910052791 calcium Inorganic materials 0.000 claims description 4
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 4
- 229960002079 calcium pantothenate Drugs 0.000 claims description 4
- 239000011669 selenium Substances 0.000 claims description 4
- 229910052711 selenium Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000011715 vitamin B12 Substances 0.000 claims description 4
- 239000011716 vitamin B2 Substances 0.000 claims description 4
- 239000011726 vitamin B6 Substances 0.000 claims description 4
- 239000011701 zinc Substances 0.000 claims description 4
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 3
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 229960000304 folic acid Drugs 0.000 claims description 3
- 235000019152 folic acid Nutrition 0.000 claims description 3
- 239000011724 folic acid Substances 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 3
- 239000011772 phylloquinone Substances 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 235000019155 vitamin A Nutrition 0.000 claims description 3
- 239000011719 vitamin A Substances 0.000 claims description 3
- 239000011647 vitamin D3 Substances 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- 229940045997 vitamin a Drugs 0.000 claims description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 235000013372 meat Nutrition 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 210000004080 milk Anatomy 0.000 claims description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 2
- 230000001804 emulsifying effect Effects 0.000 claims 1
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 claims 1
- 229960005055 sodium ascorbate Drugs 0.000 claims 1
- 235000010378 sodium ascorbate Nutrition 0.000 claims 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 241000411851 herbal medicine Species 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 4
- 230000003908 liver function Effects 0.000 abstract description 3
- 241000209149 Zea Species 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 1
- 238000001243 protein synthesis Methods 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 230000014616 translation Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 9
- 235000010755 mineral Nutrition 0.000 description 6
- 239000007789 gas Substances 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 4
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 208000019423 liver disease Diseases 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 3
- 239000011691 vitamin B1 Substances 0.000 description 3
- 241000218176 Corydalis Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- GDSOZVZXVXTJMI-SNAWJCMRSA-N (e)-1-methylbut-1-ene-1,2,4-tricarboxylic acid Chemical compound OC(=O)C(/C)=C(C(O)=O)\CCC(O)=O GDSOZVZXVXTJMI-SNAWJCMRSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000012239 Developmental disease Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 1
- 206010061998 Hepatic lesion Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010019837 Hepatocellular injury Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003035 anti-peroxidant effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 229930187479 gypenoside Natural products 0.000 description 1
- ZRBFCAALKKNCJG-UHFFFAOYSA-N gypenoside-XVII Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O ZRBFCAALKKNCJG-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开一种肝功能衰竭患者特殊医学用途配方食品，其含有大豆肽粉、乳清蛋白、蛋黄粉、玉米低聚肽粉、姜黄提取物、绞股蓝提取物、葛根提取物、低聚异麦芽糖、木糖醇、糊精、复合维生素、复合矿物质、香精。本发明采用高科技的低聚肽、维生素、矿物质与中草药中的天然成分配伍使用，起到增加机体免疫力、保护肝脏的作用。大豆肽粉、玉米低聚肽粉等低聚肽在参与机体蛋白质合成的同时，有助于提高机体的免疫力，有利于肝功能的恢复和预防感染。
Description
技术领域
本发明涉及一种特殊医学用途配方食品，尤其是涉及一种能够补充肝功能衰竭患者必需营养素，有利于满足机体营养需要的配方食品。
背景技术
多种原因可导致肝脏的病变，如病毒性、酒精性、中毒性和自身免疫性等。肝炎、肝硬化、肝癌，是肝脏病变的三步曲，也是肝脏功能不断衰竭、丧失的演变过程。当肝脏组织发生纤维化时，肝脏功能已经受到严重的损害。肝功能衰竭患者会出现多方面的代谢异常。所以，肝病病人的营养支持与调理非常重要。“富贵的肝病”也正说明肝脏疾病特别需要饮食的调理。
发明内容
本发明的目的是针对肝功能衰竭患者的营养需求，提供了一种包含蛋白质、维生素、矿物质、中草药有效成分等的特殊医学用途配方食品，可以起到增加机体免疫力、保护肝脏的作用。
本发明是以如下技术方案实现的：一种肝功能衰竭患者特殊医学用途配方食品含有大豆肽粉30-50份、乳清蛋白10-15份、蛋黄粉2-5份、玉米低聚肽粉25-45份、姜黄提取物3-6份、绞股蓝提取物2-6份、葛根提取物4-7份、低聚异麦芽糖2-6份、木糖醇1-3份、糊精1-2份、复合维生素0.1-0.5份、复合矿物质0.1-1份、香精0.05-0.5份。
一种肝功能衰竭患者特殊医学用途配方食品，所述的香精为水果类香精、奶类香精、肉类香精、蔬菜类香精、坚果类香精、蜜饯类香精、乳化类香精中的一种或几种。
一种肝功能衰竭患者特殊医学用途配方食品，所述的维生素为β—胡萝卜素、抗坏血酸钠、烟酰胺、维生素E、维生素A、泛酸钙、维生素D3、维生素B1、维生素B6、维生素B2、维生素K1、叶酸、生物素、维生素B12中的一种、几种或全部混合。
一种肝功能衰竭患者特殊医学用途配方食品，所述的矿物质为钾、镁、钙、钠、铁、锌、铜、锰、硒中的一种、几种或全部混合。
大豆肽粉、玉米低聚肽粉是小分子低聚肽，优于氨基酸或蛋白质的直接吸收，更易被人体吸收，它可不经胃肠消化，直接进入小肠被吸收，而且不受身体状况所影响。肽粉含有多种生物活性肽，具有多种生理活性，包括抗氧化、降血压、降低胆固醇、降血脂、抗疲劳、增强免疫等。
葛根味甘辛,主入脾胃，可以发表解肌,升阳透疹,解热生津，是常用中草药之一。古代《千金方》中曾有记载葛根治酒醉不醒。研究报道葛根具有多种生物学功能,如抗肿瘤、抗细菌、抗病毒、抗炎症、降血压、增强冠状动脉血流量、减慢心率、抵抗自发性心律不齐的作用。现代药理学的理论认为，葛根的有效成分有葛根素、葛根总黄酮等。葛根素具有清除氧自由基和抗脂质过氧化的作用，能减轻脂质过氧化对肝细胞损害；葛根素还可以改善肝细胞的能量代谢，从而实现其保肝效果。葛根黄酮具有植物雌激素作用，它可以显著降低肝脏中甘油三酯的含量，显著改善脂质代谢作用。有研究报道，葛根提取物还具有一定抗癌活性。
《本草求真》：姜黄，功用颇类郁金、三棱、蓬术、延胡索，但郁金入心，专泻心胞之血；莪术入肝，治气中之血；三棱入肝，治血中之气；延胡索则于心肝血分行气，气分行血；此则入脾，既治气中之血，复兼血中之气耳。陈藏器曰：此药辛少苦多，性气过于郁金，破血立通，下气最速，凡一切结气积气，症瘕瘀血，血闭痈疽，并皆有效，以其气血兼理耳。
绞股蓝主要有效成份是绞股蓝皂甙、绞股蓝糖甙(多糖)、水溶性氨基酸、黄酮类、多种维生素、微量元素、矿物质等。性味：味苦；微甘；性凉。功效：益气健脾，化痰止咳，清热解毒。主治：体虚乏力；虚劳失精；白细胞减少症；高脂血症；病毒性肝炎；慢性胃肠炎；慢性气管炎。
本发明的有益效果是：本发明将现代营养学研究成果与传统养生保健理论相结合，研制出了一种肝功能衰竭患者特殊医学用途配方食品。通过各种配料的有机组合，将各种功能进行融合，并通过有效成分之间的协同作用，增强作用效果。按本发明配方制作的食品可以为肝功能衰竭患者提供所需营养成分，尤其是易于被机体吸收利用的蛋白质，还可以增强患者的抵抗力。且口感良好、风味独特。工艺简单，易操作，适宜工厂规模化生产。
具体实施方式
下面结合实施例对本发明做进一步描述。
实施例1
本实施例的组分及重量份数为：大豆肽粉38份、乳清蛋白14份、蛋黄粉4份、玉米低聚肽粉40份、姜黄提取物4份、绞股蓝提取物3份、葛根提取物5份、低聚异麦芽糖5份、木糖醇2份、糊精1.3份、复合维生素0.361份（β—胡萝卜素0.12份、烟酰胺0.02份、维生素E0.045份、维生素A0.018份、泛酸钙0.03份、维生素D30.02份、维生素B10.01份、维生素B60.02份、维生素B20.015份、维生素K10.005份、叶酸0.02份、生物素0.02份、维生素B120.018份）、复合矿物质0.266份（钾0.011份、镁0.022份、钙0.11份、钠0.03份、铁0.005份、锌0.08份、铜0.005份、锰0.001份、硒0.002份）、水蜜桃香精0.08份。
将上述原料混合，搅拌均匀，经过干燥，制成粉状食品。用一定量温开水冲调后，可直接食用。
实施例2
本实施例的组分及重量份数为：大豆肽粉45份、乳清蛋白12份、蛋黄粉4份、玉米低聚肽粉36份、姜黄提取物5份、绞股蓝提取物4份、葛根提取物6份、低聚异麦芽糖3份、木糖醇1.6份、糊精1.2份、复合维生素0.16份（烟酰胺0.01份、维生素A0.03份、泛酸钙0.014份、维生素B10.014份、维生素B60.013份、维生素B20.017份、维生素K10.004份、生物素0.032份、维生素B120.026份）、复合矿物质0.1146份（锌0.05份、锰0.001份、硒0.0036份、钙0.06份）、甜橙香精0.12份。
将上述原料混合，搅拌均匀，经过干燥，制成粉状食品。用一定量温开水冲调后，可直接食用。
以上对本发明进行了详细介绍，以上实施例的说明只是用于帮助理解本发明。本领域的普通技术人员应当理解，可以对本发明的技术方案进行更动、润饰或者等同替换，而不脱离本发明技术方案的精神和范围，其均应属于本发明的权利要求保护范围当中。
Claims (4)
1.一种肝功能衰竭患者特殊医学用途配方食品，其特征在于它含有大豆肽粉30-50份、乳清蛋白10-15份、蛋黄粉2-5份、玉米低聚肽粉25-45份、姜黄提取物3-6份、绞股蓝提取物2-6份、葛根提取物4-7份、低聚异麦芽糖2-6份、木糖醇1-3份、糊精1-2份、复合维生素0.1-0.5份、复合矿物质0.1-1份、香精0.05-0.5份。
2.根据权利要求1所述的一种肝功能衰竭患者特殊医学用途配方食品，其特征在于，所述的香精为水果类香精、奶类香精、肉类香精、蔬菜类香精、坚果类香精、蜜饯类香精、乳化类香精中的一种或几种。
3.根据权利要求1所述的一种肝功能衰竭患者特殊医学用途配方食品，其特征在于，所述的维生素为β—胡萝卜素、抗坏血酸钠、烟酰胺、维生素E、维生素A、泛酸钙、维生素D3、维生素B1、维生素B6、维生素B2、维生素K1、叶酸、生物素、维生素B12中的一种、几种或全部混合。
4.根据权利要求1所述的一种肝功能衰竭患者特殊医学用途配方食品，其特征在于，所述的矿物质为钾、镁、钙、钠、铁、锌、铜、锰、硒中的一种、几种或全部混合。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610508911.4A CN106072564A (zh) | 2016-07-02 | 2016-07-02 | 一种肝功能衰竭患者特殊医学用途配方食品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610508911.4A CN106072564A (zh) | 2016-07-02 | 2016-07-02 | 一种肝功能衰竭患者特殊医学用途配方食品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106072564A true CN106072564A (zh) | 2016-11-09 |
Family
ID=57211620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610508911.4A Withdrawn CN106072564A (zh) | 2016-07-02 | 2016-07-02 | 一种肝功能衰竭患者特殊医学用途配方食品 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106072564A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110604315A (zh) * | 2019-10-12 | 2019-12-24 | 襄阳市世诠生物科技有限公司 | 一种满足肝病患者营养需求的组合物及其制备方法 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101496578A (zh) * | 2008-01-28 | 2009-08-05 | 中国食品发酵工业研究院 | 一种供肝病患者食用含短肽的特殊膳食用食品配方 |
| US20110152184A1 (en) * | 2008-07-02 | 2011-06-23 | N.V. Nutricia | Nutritional Composition for Improving Muscle Function and Daily Activity |
| AU2010237335A1 (en) * | 2009-04-15 | 2011-11-03 | Sudzucker Aktiengesellschaft Mannheim/Ochsenfurt | Trehalulose-containing composition, its preparation and use |
| CN103932173A (zh) * | 2014-03-25 | 2014-07-23 | 姜利 | 一种解酒护肝的组合物 |
| CN104606275A (zh) * | 2014-04-10 | 2015-05-13 | 宁波市第二医院 | 一种防治脂肪肝的中药有效组分复方 |
| CN104872646A (zh) * | 2015-04-24 | 2015-09-02 | 劲膳美生物科技股份有限公司 | 大肠癌非全营养配方食品 |
-
2016
- 2016-07-02 CN CN201610508911.4A patent/CN106072564A/zh not_active Withdrawn
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101496578A (zh) * | 2008-01-28 | 2009-08-05 | 中国食品发酵工业研究院 | 一种供肝病患者食用含短肽的特殊膳食用食品配方 |
| US20110152184A1 (en) * | 2008-07-02 | 2011-06-23 | N.V. Nutricia | Nutritional Composition for Improving Muscle Function and Daily Activity |
| RU2506825C2 (ru) * | 2008-07-02 | 2014-02-20 | Н.В. Нутрисия | Питательная композиция для улучшения мышечной функции и суточной активности |
| AU2010237335A1 (en) * | 2009-04-15 | 2011-11-03 | Sudzucker Aktiengesellschaft Mannheim/Ochsenfurt | Trehalulose-containing composition, its preparation and use |
| CN103932173A (zh) * | 2014-03-25 | 2014-07-23 | 姜利 | 一种解酒护肝的组合物 |
| CN104606275A (zh) * | 2014-04-10 | 2015-05-13 | 宁波市第二医院 | 一种防治脂肪肝的中药有效组分复方 |
| CN104872646A (zh) * | 2015-04-24 | 2015-09-02 | 劲膳美生物科技股份有限公司 | 大肠癌非全营养配方食品 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110604315A (zh) * | 2019-10-12 | 2019-12-24 | 襄阳市世诠生物科技有限公司 | 一种满足肝病患者营养需求的组合物及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104799146A (zh) | 一种改善亚健康的功能性营养食品组合及其制备方法 | |
| CN106174474A (zh) | 一种适用于心脑血管疾病患者食用的特膳食品 | |
| CN105942498A (zh) | 具有治疗糖尿病作用的功能性营养食品组合及其制备方法 | |
| CN104855984A (zh) | 过敏性鼻炎非全营养配方食品 | |
| CN104922550A (zh) | 一种中药组合物及其应用 | |
| CN104172186A (zh) | 一种调理肝肿瘤的方便食品 | |
| CN104886552A (zh) | 慢性胃炎非全营养配方食品 | |
| CN100566582C (zh) | 强肾益寿保健茶 | |
| CN105999233A (zh) | 一种治疗女性不孕不育的药物及其制备方法 | |
| CN104855975A (zh) | 肌肉衰减综合征非全营养配方食品 | |
| CN104855968A (zh) | 肝癌非全营养配方食品 | |
| CN104839698A (zh) | 心血管疾病非全营养配方食品 | |
| CN104872638A (zh) | 便秘非全营养配方食品 | |
| CN106165900A (zh) | 一种糖尿病患者特殊医学用途配方食品 | |
| CN105995303A (zh) | 一种红参饮品及其制备方法 | |
| CN103734767B (zh) | 一种保健食品 | |
| CN104855970A (zh) | 高血压非全营养配方食品 | |
| CN106261200A (zh) | 葛根素和绞股蓝皂苷制备防三高饮品的工艺 | |
| CN104855972A (zh) | 妇女延更调理非全营养配方食品 | |
| CN104872646A (zh) | 大肠癌非全营养配方食品 | |
| CN107410816A (zh) | 一种扶阳补元药食两用植物特膳食品 | |
| CN106072564A (zh) | 一种肝功能衰竭患者特殊医学用途配方食品 | |
| CN106136235A (zh) | 一种肿瘤病人特殊医学用途配方食品 | |
| CN104856008A (zh) | 萎缩性胃炎非全营养配方食品 | |
| CN104855969A (zh) | 肝病非全营养配方食品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20161109 |
|
| WW01 | Invention patent application withdrawn after publication |